Banyan Partners, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 86 filers reported holding IMMUNOMEDICS INC in Q4 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Banyan Partners, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2014$725,000
+1.8%
195,0000.0%0.06%
+3.3%
Q2 2014$712,000
-13.3%
195,0000.0%0.06%
-15.5%
Q1 2014$821,000
-8.5%
195,0000.0%0.07%
+12.7%
Q4 2013$897,000
-17.3%
195,000
+11.4%
0.06%
-34.4%
Q3 2013$1,085,000
+14.0%
175,0000.0%0.10%
-48.7%
Q2 2013$952,000175,0000.19%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders